BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16488952)

  • 1. Deep sclerectomy and low dose mitomycin C: a randomised prospective trial in west Africa.
    Mielke C; Dawda VK; Anand N
    Br J Ophthalmol; 2006 Mar; 90(3):310-3. PubMed ID: 16488952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep sclerectomy augmented with mitomycin C.
    Anand N; Atherley C
    Eye (Lond); 2005 Apr; 19(4):442-50. PubMed ID: 15746961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonpenetrating deep sclerectomy with the use of adjunctive mitomycin C.
    Neudorfer M; Sadetzki S; Anisimova S; Geyer O
    Ophthalmic Surg Lasers Imaging; 2004; 35(1):6-12. PubMed ID: 14750756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep sclerectomy versus trabeculectomy with low-dosage mitomycin C: four-year follow-up.
    Cillino S; Di Pace F; Casuccio A; Cillino G; Lodato G
    Ophthalmologica; 2008; 222(2):81-7. PubMed ID: 18303227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep sclerectomy with mitomycin C in failed trabeculectomy.
    Rebolleda G; Muñoz-Negrete FJ
    Eye (Lond); 2007 Jan; 21(1):23-8. PubMed ID: 16311522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep sclerectomy versus punch trabeculectomy: effect of low-dosage mitomycin C.
    Cillino S; Di Pace F; Casuccio A; Lodato G
    Ophthalmologica; 2005; 219(5):281-6. PubMed ID: 16123554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitomycin-C-augmented deep sclerectomy in patients with primary open-angle glaucoma and exfoliation glaucoma: a 1-year prospective study.
    Ollikainen M; Puustjärvi T; Rekonen P; Uusitalo H; Teräsvirta M
    Acta Ophthalmol; 2010 Feb; 88(1):20-6. PubMed ID: 19432842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of adjunctive mitomycin C during Ahmed Glaucoma Valve implantation: a prospective randomized clinical trial.
    Costa VP; Azuara-Blanco A; Netland PA; Lesk MR; Arcieri ES
    Ophthalmology; 2004 Jun; 111(6):1071-6. PubMed ID: 15177955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined phacoemulsification and deep sclerectomy (PDS) with intraoperative mitomycin C (MMC) augmentation.
    Anand S; Anand N
    Eye (Lond); 2008 Aug; 22(8):1040-9. PubMed ID: 17464299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep sclerectomy in one eye vs deep sclerectomy with collagen implant in the contralateral eye of the same patient: long-term follow-up.
    Shaarawy T; Mermoud A
    Eye (Lond); 2005 Mar; 19(3):298-302. PubMed ID: 15258610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of low-dose intraoperative mitomycin-C vs 5-fluorouracil in primary glaucoma surgery: a pilot study.
    Vijaya L; Mukhesh BN; Shantha B; Ramalingam S; Sathi Devi AV
    Ophthalmic Surg Lasers; 2000; 31(1):24-30. PubMed ID: 10976557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of nonpenetrating deep sclerectomy with reticulated hyaluronic acid implant SKGEL and/or preoperative application of 5-luorouracil: results of 2 and a half years].
    Detry-Morel M; De Temmerman S
    Bull Soc Belge Ophtalmol; 2003; (287):53-62. PubMed ID: 12784578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of adjunctive mitomycin C in secondary glaucoma triple procedure as compared to primary glaucoma triple procedure.
    Shin DH; Kim YY; Sheth N; Ren J; Shah M; Kim C; Yang KJ
    Ophthalmology; 1998 Apr; 105(4):740-5. PubMed ID: 9544650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of deep sclerectomy and phacoemulsification and deep sclerectomy in clinical material of Military Health Service Institute--yearly observations.
    Marek R; Joanna W; Lewczuk K; Siemiatkowska A; Stankiewicz A
    Klin Oczna; 2006; 108(10-12):385-91. PubMed ID: 17455710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing polymethylmethacrylate implant with collagen implant in deep sclerectomy: a randomized controlled trial.
    Mansouri K; Shaarawy T; Wedrich A; Mermoud A
    J Glaucoma; 2006 Jun; 15(3):264-70. PubMed ID: 16778652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma.
    Fontana H; Nouri-Mahdavi K; Lumba J; Ralli M; Caprioli J
    Ophthalmology; 2006 Jun; 113(6):930-6. PubMed ID: 16647135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of intraoperative 5-fluorouracil versus intraoperative mitomycin C in primary trabeculectomy surgery.
    Palanca-Capistrano AM; Hall J; Cantor LB; Morgan L; Hoop J; WuDunn D
    Ophthalmology; 2009 Feb; 116(2):185-90. PubMed ID: 18930550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-penetrating deep sclerectomy in the treatment of advanced cases of open angle glaucoma].
    Gierek-Lapińska A; Leszczyński R; Wróbel A
    Klin Oczna; 2004; 106(1-2 Suppl):168-9. PubMed ID: 15510486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep sclerectomy in normal-tension glaucoma with and without mitomycin-c.
    Suominen S; Harju M; Kurvinen L; Vesti E
    Acta Ophthalmol; 2014 Nov; 92(7):701-6. PubMed ID: 24373326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nine-year follow-up of trabeculectomy with or without low-dosage mitomycin-c in primary open-angle glaucoma.
    Reibaldi A; Uva MG; Longo A
    Br J Ophthalmol; 2008 Dec; 92(12):1666-70. PubMed ID: 18782799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.